GT201300182A - METHOD FOR THE TREATMENT OF AN INFECTION - Google Patents

METHOD FOR THE TREATMENT OF AN INFECTION

Info

Publication number
GT201300182A
GT201300182A GT201300182A GT201300182A GT201300182A GT 201300182 A GT201300182 A GT 201300182A GT 201300182 A GT201300182 A GT 201300182A GT 201300182 A GT201300182 A GT 201300182A GT 201300182 A GT201300182 A GT 201300182A
Authority
GT
Guatemala
Prior art keywords
treatment
composition
antico
antibiotics
water solvent
Prior art date
Application number
GT201300182A
Other languages
Spanish (es)
Inventor
Fadil Al Alawi
Wayne Frederick Leech
Karthigeyan Nanjan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46515931&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201300182(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT201300182A publication Critical patent/GT201300182A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE SE REFIERE A UNA COMPOSICIÓN INYECTABLE CUANDO SE UTILIZA PARA EL TRATAMIENTO DE UNA INFECCIÓN MICROBIANA EN UNA GLÁNDULA MAMARIA DE UN ANIMAL, EN EL QUE LA COMPOSICIÓN INCLUYE A) UN FÁRMACO ANTI-INFLAMATORIO NO ESTEROIDEO (AINE)B) UN ANTIBIÓTICO SELECCIONADO DE ENTRE EL GRUPO QUE CONSISTE DE UN ANTIBIÓTICO BETA LACTÁMICO Y MACRÓLIDOCARACTERIZADO PORQUE LA COMPOSICIÓN INCLUYE UN DISOLVENTE NO ACUOSO, Y EL AINE Y LOS ANTIBIÓTICOS EN LA COMPOSICIÓN SE DISUELVE EN EL DISOLVENTE NO ACUOSO.THIS REFERENCES TO AN INJECTABLE COMPOSITION WHEN IT IS USED FOR THE TREATMENT OF A MICROBIAL INFECTION IN A MAMMARY GLAND OF AN ANIMAL, IN WHICH THE COMPOSITION INCLUDES a) AN ANTI-INFLAMMATORY DRUG NOT STIOID ANTICO BOTTOM ANTICO BOTTOM (AINE) BETWEEN THE GROUP THAT CONSISTS OF A BETA LACTAMIC AND MACRÓLIDACTERIZED ANTIBIOTICS BECAUSE THE COMPOSITION INCLUDES A NON-WATER SOLVENT, AND THE NSAID AND THE ANTIBIOTICS IN THE COMPOSITION DISSOLVES IN THE NON-WATER SOLVENT.

GT201300182A 2011-01-20 2013-07-17 METHOD FOR THE TREATMENT OF AN INFECTION GT201300182A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ588686A NZ588686A (en) 2011-01-20 2011-01-20 Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland

Publications (1)

Publication Number Publication Date
GT201300182A true GT201300182A (en) 2014-07-28

Family

ID=46515931

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201300182A GT201300182A (en) 2011-01-20 2013-07-17 METHOD FOR THE TREATMENT OF AN INFECTION

Country Status (15)

Country Link
KR (1) KR101905173B1 (en)
CN (1) CN103327984B (en)
AU (1) AU2012207698A1 (en)
BR (1) BR112013018557B1 (en)
CL (1) CL2013002086A1 (en)
CO (1) CO6801732A2 (en)
CR (1) CR20130401A (en)
GT (1) GT201300182A (en)
IL (1) IL227540A (en)
MX (1) MX353876B (en)
NI (1) NI201300063A (en)
NZ (1) NZ588686A (en)
PE (1) PE20140035A1 (en)
WO (1) WO2012099479A1 (en)
ZA (1) ZA201305780B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2995297A1 (en) * 2014-09-09 2016-03-16 Ceva Sante Animale Parenteral compositions and uses thereof
AR102172A1 (en) 2015-10-05 2017-02-08 Química Luar S R L A BACTERICIDE AND VIRUCIDE PHARMACEUTICAL COMPOSITION
CN105663037A (en) * 2016-01-27 2016-06-15 成都乾坤动物药业有限公司 Amoxicillin solution as well as preparation method and application thereof
CN112472667B (en) * 2019-08-23 2022-11-15 北京欧博方医药科技有限公司 Retxib long-acting injection and preparation method and application thereof
CN111035614B (en) * 2019-12-20 2024-02-02 北京喜禽药业有限公司 High-content terramycin injection and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
CN1297319C (en) * 2003-09-22 2007-01-31 王玉万 Preparing pharmaceutics of medication containing antimicrobials by using silicone oil as medium
US20050148519A1 (en) 2003-10-29 2005-07-07 Murthy Yerramilli V.S. Salts of pharmacologically active compounds
DE102004025324A1 (en) * 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation for veterinary medicine, process for their preparation and their use

Also Published As

Publication number Publication date
NI201300063A (en) 2014-05-23
KR101905173B1 (en) 2018-11-28
ZA201305780B (en) 2014-04-30
CR20130401A (en) 2014-02-04
AU2012207698A1 (en) 2013-04-18
BR112013018557A2 (en) 2016-11-22
NZ588686A (en) 2013-07-26
CN103327984A (en) 2013-09-25
IL227540A (en) 2017-12-31
KR20140012646A (en) 2014-02-03
WO2012099479A1 (en) 2012-07-26
IL227540A0 (en) 2013-09-30
BR112013018557B1 (en) 2021-11-03
MX353876B (en) 2018-02-01
PE20140035A1 (en) 2014-02-16
CL2013002086A1 (en) 2014-07-25
CN103327984B (en) 2016-08-17
CO6801732A2 (en) 2013-11-29
MX2013008407A (en) 2013-09-26

Similar Documents

Publication Publication Date Title
CL2019001551A1 (en) 7-phenylethylamino-4h-pyrimido [4,5-d] [1,3] -oxazin-2-one compounds as mutant idh1 and idh2 inhibitors
CL2017003404A1 (en) Antibacterial compounds
CL2018003681A1 (en) Boronic acid derivatives and therapeutic uses thereof
CO2019009258A2 (en) Fast and controlled administration of compositions with restored entourage effects
CR20140541A (en) NON-WATER THERMAL PHARMACEUTICAL FORMULATIONS
CL2009000178A1 (en) Composition comprising an antibody against domain II of her2, its acid variants, sequences that comprise its light and heavy chains; pharmaceutical formulation comprising said antibody and its use for her2 positive cancer.
UY34649A (en) HETEROBICYCLIC COMPOUNDS
CL2019003398A1 (en) Pyrazole magl inhibitors.
UY33775A (en) MACROCYCLIC INHIBITORS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND THEIR USES
CL2017000984A1 (en) Reduction of the viscosity of pharmaceutical formulations
ES2552754T1 (en) Daptomycin formulations and uses thereof
GT201300182A (en) METHOD FOR THE TREATMENT OF AN INFECTION
CR20160433A (en) NEW COMPOUNDS
CL2015002755A1 (en) Antibiotic compositions of ceftolozano.
SV2017005466A (en) PIRAZOLPIRIDINAMINS AS INHIBITORS OF MKNK1 AND MKNK2
CU20160072A7 (en) TIENOPIRIMIDINS AS MKNK1 AND MKNK2 INHIBITORS
DOP2016000007A (en) SUBSTITUTED PIRAZOLPIRIDINS
CL2019002340A1 (en) Compositions and methods for promoting hair growth with mpc1 inhibitors.
UY36373A (en) COMPOUNDS FOR USE IN ANTIHELMINTIC TREATMENT
CL2013003111A1 (en) Method for the preparation of a pharmaceutical composition containing a purified and thermally stable oxygen transporter, which contains the hemoglobin oxygen transporter, where hemoglobin includes crosslinked polymeric hemoglobin.
DOP2016000268A (en) AMIDO-AZOLE COMPOUNDS SUBSTITUTED AS TNKS1 AND/OR TNKS2 INHIBITORS
BR112017008033A2 (en) For oral administration the pharmaceutical composition comprising the taxane
PE20150167A1 (en) (R) -NIFURATEL, ITS USE FOR THE TREATMENT OF INFECTIONS AND SYNTHESIS OF (R) AND (S) -NIFURATEL
CO6300935A2 (en) ORAL AND INJECTABLE FORMULATIONS OF TETRACICLINE COMPOUNDS
CY1120016T1 (en) PHARMACEUTICAL FORMS OF ACP KASPOFUNGIN